Key facts
- Notable investors include Legend Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Hanxing Kangji
- ·The full record, as it builds
Funding rounds
No funding rounds for Hanxing Kangji are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hanxing Kangji
Manufacturer of biopharmaceutical technologies intended to advance medical research and therapeutic innovation. The company offers expertise in biotechnology development, medical device distribution, and artificial intelligence applications, enabling healthcare providers and research institutions to improve patient care and accelerate scientific progress.
- Sector
- Healthcare
- HQ
- Chengdu, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Hanxing Kangji doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hanxing Kangji shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hanxing Kangji in its N-PORT filings yet. We sweep new filings monthly.